Amrutanjan Opens New Sanitary Napkin Factory In Telangana

Market snapshot: Amrutanjan Healthcare has expanded its manufacturing footprint with the opening of a new sanitary napkin factory in Telangana (as stated in the source alert; not independently verified). This strategic move transitions the production of its 'Comfy' brand of sanitary napkins in-house, shifting away from a reliance on third-party manufacturers.

Data Snapshot

• The company recorded total revenue of ₹94.05 crore for Q1 FY27, up 12.31% YoY.
• Standalone net profit for Q1 FY27 stood at ₹8.31 crore, showing an 80.07% YoY growth.
• Amrutanjan maintains a zero-debt balance sheet over the last five fiscal years.
• The company's Board originally approved a capital expenditure of ₹123 crore for setting up the sanitary napkin plant in May 2024.

What's Changed

• Amrutanjan transitions from outsourcing its 'Comfy' sanitary napkins via third-party manufacturing to direct in-house production.
• Feminine hygiene segment's profitability is expected to improve as in-house manufacturing resolves margin pressure previously caused by high raw material costs and outsourcing fees.
• The projected plant investment of ₹150 crore (as stated in the source alert; not independently verified) reflects an escalation from the initial ₹123 crore board approval in 2024.

Key Takeaways

• Amrutanjan has commenced operations at its new sanitary napkin facility in Telangana, aimed at supporting domestic and export market opportunities.
• The plant transition directly improves margin capture for the 'Comfy' brand, which had grown 38% in FY24 to ₹108.24 crore but faced competitive pricing pressures.
• The project is aligned with federal manufacturing incentives, following the company's approval under the third round of the textiles PLI scheme in June 2026.
• Amrutanjan enters this operational expansion with robust liquidity, highlighted by ₹0 debt and an 80.07% YoY net income surge in Q1 FY27.

SAHI Perspective

By bringing the manufacturing of Comfy sanitary pads in-house, Amrutanjan addresses the principal margin headwind of its highest-growth segment. Historically, the brand suffered from lower profitability because it relied on third-party suppliers. Direct control over production capacity allows the company to execute product-level design innovations and capitalize on the central government's PLI scheme benefits. Despite a recent one-time ₹9.75 crore lease payment outflow, the company's zero-debt profile and rising cash accruals ensure its balance sheet remains resilient during this capital-intensive phase.

Market Implications

The shift to in-house production strengthens Amrutanjan's positioning in the highly competitive feminine hygiene sector, allowing it to compete more effectively on pricing against dominant players. Improved operating margins from the Telangana facility should support higher advertising and marketing spend, driving volume market share gains for the Comfy brand, particularly in rural and semi-urban target markets.

Trading Signals

Market Bias: Bullish

The transition to high-margin in-house manufacturing for the Comfy brand, coupled with PLI scheme incentives and strong Q1 FY27 net income growth (up 80.07% YoY to ₹8.31 crore), supports a positive medium-term outlook for the stock.

Overweight: FMCG, Consumer Healthcare, Textiles / Hygiene

Trigger Factors:

• Capacity utilization ramp-up at the Telangana plant.
• Margin improvements visible in subsequent quarterly reports.
• Market share gains for the Comfy brand.

Time Horizon: Medium-term (3-12 months)

Industry Context

The Indian feminine hygiene market remains underpenetrated, particularly in rural regions. Key players face intense price competition and require strong distribution networks. While MNCs dominate, domestic players like Amrutanjan are leveraging lower cost structures and deep distribution networks (over 1.13 million outlets) to capture market share. The central government's PLI scheme for textiles further enhances the viability of domestic manufacturing units.

Key Risks to Watch

• Raw material cost inflation, particularly for imported wood pulp and superabsorbent polymers, which can compress margins.
• Execution risks in ramping up the new facility's capacity to its reported 700 million annual target.
• High competitive intensity from established global brands and regional low-cost entrants.

Recent Developments

On August 1, 2026, Amrutanjan settled lease rent arrears of ₹9.75 crore with Kapaleeswarar Temple in compliance with a Madras High Court directive, reporting no material impact on operations. On July 3, 2026, the company reported solid Q1 FY27 results with revenue up 12.31% YoY to ₹94.05 crore. In June 2026, the company was selected as an approved applicant under the third round of the central government's ₹10,683 crore PLI scheme for textiles in Telangana.

Closing Insight

Amrutanjan's transition to in-house manufacturing for its feminine hygiene segment represents a matured corporate shift. By utilizing internal accruals to build direct production capacity, the company aligns its high-growth brand with sustainable, long-term unit economics.

High Performance Trading with SAHI.